Literature DB >> 24219060

Effect of hyaluronan tetrasaccharides on epidermal differentiation in normal human epidermal keratinocytes.

M Kage1, Y Tokudome1, Y Matsunaga2, T Hariya2, F Hashimoto1.   

Abstract

OBJECTIVE: Hyaluronan (HA) plays a role in keratinocyte proliferation and differentiation. In addition, HA has been shown to have different biological activities depending on its molecular weight. It has been reported that HA-mediated CD44 activation regulates keratinocyte differentiation. Therefore, the aim of this study was to investigate the influence of HA tetrasaccharides (HA4) on the regulation of keratinocyte differentiation, CD44 gene expression and CD44-phosphorylated protein in human keratinocytes, and compare HA4 with high molecular weight HA.
METHODS: Normal human epidermal keratinocytes (NHEKs) were treated at doses of 1 μg mL(-1) HA or HA oligosaccharides (HA4). After treatment, cell viability was checked using an MTT (3-(4,5-di-methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. Each differentiation marker and CD44 mRNA expression was detected by real-time PCR. Each differentiation marker and CD44-phosphorylated protein was assessed by Western blotting.
RESULTS: Hyaluronan and HA4 showed no cytotoxicity up to a dose of 1 μg mL(-1) . On day 3 after HA4 treatment, each differentiation marker mRNA and K10 protein level was higher than that of the control. On day 9, late differentiation marker mRNA and protein levels were increased with HA and HA4 treatment. In addition, HA4 treatment increased the expression of CD44 mRNA, CD44-phosphorylated protein and intracellular calcium concentrations. HA4 enhanced keratinocyte differentiation and increased CD44-phosphorylated protein levels.
CONCLUSION: HA4 may induce epidermal differentiation through phosphorylation of CD44.
© 2013 Society of Cosmetic Scientists and the Société Française de Cosmétologie.

Entities:  

Keywords:  CD44 phosphorylation; hyaluronan oligosaccharide; keratinocyte differentiation

Mesh:

Substances:

Year:  2013        PMID: 24219060     DOI: 10.1111/ics.12105

Source DB:  PubMed          Journal:  Int J Cosmet Sci        ISSN: 0142-5463            Impact factor:   2.970


  7 in total

1.  First Use of Thermal Stabilized Hyaluronic Acid Injection in One-Year Follow-Up Patients with Genitourinary Syndrome.

Authors:  Elisabetta Garavaglia; Cinzia Sala; Manuela Busato; Gilberto Bellia; Nadia Tamburlin; Alberto Massirone
Journal:  Med Devices (Auckl)       Date:  2020-12-04

Review 2.  Matrix hyaluronan-activated CD44 signaling promotes keratinocyte activities and improves abnormal epidermal functions.

Authors:  Lilly Y W Bourguignon
Journal:  Am J Pathol       Date:  2014-05-09       Impact factor: 4.307

Review 3.  Hyaluronan and RHAMM in wound repair and the "cancerization" of stromal tissues.

Authors:  Cornelia Tolg; James B McCarthy; Arjang Yazdani; Eva A Turley
Journal:  Biomed Res Int       Date:  2014-08-04       Impact factor: 3.411

4.  Hyaluronan-phosphatidylethanolamine polymers form pericellular coats on keratinocytes and promote basal keratinocyte proliferation.

Authors:  Caitlin J Symonette; Aman Kaur Mann; Xiao Cherie Tan; Cornelia Tolg; Jenny Ma; Francisco Perera; Arjang Yazdani; Eva A Turley
Journal:  Biomed Res Int       Date:  2014-09-09       Impact factor: 3.411

5.  Hyaluronan Hybrid Cooperative Complexes as a Novel Frontier for Cellular Bioprocesses Re-Activation.

Authors:  Antonietta Stellavato; Luisana Corsuto; Antonella D'Agostino; Annalisa La Gatta; Paola Diana; Patrizia Bernini; Mario De Rosa; Chiara Schiraldi
Journal:  PLoS One       Date:  2016-10-10       Impact factor: 3.240

6.  A Connecting Link between Hyaluronan Synthase 3-Mediated Hyaluronan Production and Epidermal Function.

Authors:  Yukiko Ota; Hiroyuki Yoshida; Yoko Endo; Tetsuya Sayo; Yoshito Takahashi
Journal:  Int J Mol Sci       Date:  2022-02-22       Impact factor: 5.923

Review 7.  Epidermal Hyaluronan in Barrier Alteration-Related Disease.

Authors:  Céline Evrard; Catherine Lambert de Rouvroit; Yves Poumay
Journal:  Cells       Date:  2021-11-09       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.